Understanding how the brain controls inhibitory signals
Local translation mechanisms to control inhibitory synaptic plasticity
This study is looking at how certain proteins in the brain help control communication between nerve cells, which is important for understanding brain disorders, and it’s for anyone interested in how our brains adapt and change over time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10884433 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind inhibitory synaptic plasticity in the brain, focusing on how certain proteins are produced and regulated at inhibitory synapses. By examining the role of microRNAs in controlling the translation of these proteins, the study aims to uncover how synaptic strength changes over time. Using advanced imaging techniques and electrophysiological methods, researchers will explore these processes both in living organisms and in laboratory settings. This work is crucial for understanding how inhibitory signals in the brain can be sustained and modified, which has implications for various brain disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with brain disorders that involve synaptic inhibition issues.
Not a fit: Patients with conditions unrelated to synaptic plasticity or those not experiencing brain disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into treating brain disorders related to synaptic dysfunction.
How similar studies have performed: Previous research has shown promising results in understanding synaptic mechanisms, suggesting that this approach could yield valuable insights.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Smith, Katharine Rachel — University of Colorado Denver
- Study coordinator: Smith, Katharine Rachel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.